TARO-TOFACITINIB XR
TARO PHARMACEUTICALS INC
Quick answers
Is there a shortage of TARO-TOFACITINIB XR in Canada?
No. There is no current shortage of TARO-TOFACITINIB XR 11MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Closest Matches
XELJANZ XR
Extended-ReleasePFIZER CANADA ULC
Other Products
XELJANZ
PFIZER CANADA ULC
APO-TOFACITINIB
APOTEX INC
TARO-TOFACITINIB
TARO PHARMACEUTICALS INC
AURO-TOFACITINIB
AURO PHARMA INC
JAMP TOFACITINIB
JAMP PHARMA CORPORATION
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02553988
Strength
11MG
Dosage Form
Tablet (Extended-Release)
Route
Oral
Active Ingredient
TOFACITINIB (TOFACITINIB CITRATE)
See all TOFACITINIB (TOFACITINIB CITRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from TARO PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
2% · DIN 02247560
DIN 02315033
DIN 02230251
DIN 02304457
0.05% · DIN 00716618
0.1% · DIN 00716626
0.1% · DIN 00716634
0.05% · DIN 00716642
0.1% · DIN 00716650
1% · DIN 00812382
2% · DIN 00812374
1% · DIN 00812366